Latest Press Releases

19-Apr-23

Convatec secures a highly innovative technology platform in the anti-infective space

01-Mar-23

FDA clears first placental extracellular matrix medical device for management of second-degree burns

03-Jan-23

Convatec announces the introduction of ConvaFoam™

14-Mar-22

Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1

28-Jan-22

Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc

22-Nov-21

100 million lives touched as Convatec marks 25 years of AQUACEL®

08-Nov-21

Convatec awarded contract for Advanced Wound Care Products from Vizient, Inc.

21-Jun-21

Global commercial rights signed by Convatec Ltd for ChloraSolv, innovative wound debrider from RLS

31-Mar-21

Convatec awarded contract for Ostomy Products from Vizient, Inc.

24-Feb-20

Expert panel publishes Wound Hygiene consensus

14-Jan-20

Convatec announces the release of ConvaMax™

07-Jun-19

Convatec partners with EWMA to support Research Grants in 2019

17-Dec-18

Convatec Welcomes Wound Care Sector Deal

26-Oct-18

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

24-Jul-18

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

07-Apr-17

Independent Study Finds Significant Decrease in Post-Operative Joint Infections with AQUACEL® Ag SURGICAL Cover Dressing